+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Pregabalin"

From
From
Seizures Drug Pipeline Analysis Report 2025 - Product Thumbnail Image

Seizures Drug Pipeline Analysis Report 2025

  • Drug Pipelines
  • June 2025
  • 200 Pages
  • Global
From
Peripheral Neuropathic Pain Pipeline Analysis Report 2025 - Product Thumbnail Image

Peripheral Neuropathic Pain Pipeline Analysis Report 2025

  • Report
  • June 2025
  • 200 Pages
  • Global
From
Diabetic Peripheral Neuropathy Pipeline Analysis Report 2025 - Product Thumbnail Image

Diabetic Peripheral Neuropathy Pipeline Analysis Report 2025

  • Report
  • June 2025
  • 200 Pages
  • Global
From
Diabetic Neuropathic Pain Drug Pipeline Analysis Report 2025 - Product Thumbnail Image

Diabetic Neuropathic Pain Drug Pipeline Analysis Report 2025

  • Drug Pipelines
  • June 2025
  • 200 Pages
  • Global
From
From
From
From
From
From
From
From
From
From
Loading Indicator

Pregabalin is a drug used to treat a variety of conditions related to the central nervous system, including epilepsy, neuropathic pain, fibromyalgia, and generalized anxiety disorder. It is a gamma-aminobutyric acid (GABA) analog that works by binding to certain calcium channels in the brain, reducing the release of neurotransmitters that can cause pain and anxiety. Pregabalin is available in both oral and injectable forms, and is often prescribed in combination with other medications. Pregabalin is a relatively new drug, having been approved by the US Food and Drug Administration in 2004. Since then, it has become a popular treatment option for many conditions related to the central nervous system. It is generally well-tolerated and has fewer side effects than other drugs used to treat similar conditions. Some of the companies in the Pregabalin market include Pfizer, Mylan, Teva Pharmaceuticals, and Sun Pharmaceuticals. Show Less Read more